Thus, we hypothesized that potential functional genetic polymorphisms (variant alleles or haplotypes/diplotypes) in COX-2 that result in altered expression and/or activity of the protein may modulate the inflammatory response, modifying overall breast cancer risk or risk for subtypes of breast cancer. Here, PTGS2 is linked to breast carcinoma.